The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
Open accessAbstract
BACKGROUND: Cryptococcal meningitis (CM) is a leading cause of death in individuals infected with human immunodeficiency virus (HIV). Identifying factors associated with mortality informs strategies to improve outcomes. METHODS: Five hundred one patients with HIV-associated CM were followed prospectively for 10 weeks during trials in Thailand, Uganda, Malawi, and South Africa. South African patients (n = 266) were followed for 1 year. Similar inclusion/exclusion criteria were applied at all sites. Logistic regression identified baseline variables independently associated with mortality. RESULTS: Mortality was 17% at 2 weeks and 34% at 10 weeks. Altered mental status (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.7-5.9), high cerebrospinal fluid (CSF) fungal burden (OR, 1.4 per log10 colony-forming units/mL increase; 95% CI, 1.0-1.8), older age (>50 years; OR, 3.9; 95% CI, 1.4-11.1), high peripheral white blood cell count (>10 × 10(9) cells/L; OR, 8.7; 95% CI, 2.5-30.2), fluconazole-based induction treatment, and slow clearance of CSF infection were independently associated with 2-week mortality. Low body weight, anemia (hemoglobin <7.5 g/dL), and low CSF opening pressure were independently associated with mortality at 10 weeks in addition to altered mental status, high fungal burden, high peripheral white cell count, and older age. In those followed for 1 year, overall mortality was 41%. Immune reconstitution inflammatory syndrome occurred in 13% of patients and was associated with 2-week CSF fungal burden (P = .007), but not with time to initiation of antiretroviral therapy (ART). CONCLUSIONS: CSF fungal burden, altered mental status, and rate of clearance of infection predict acute mortality in HIV-associated CM. The results suggest that earlier diagnosis, more rapidly fungicidal amphotericin-based regimens, and prompt immune reconstitution with ART are priorities for improving outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A strong IFNγ response is indicative of a good prognosis in patients with cryptococcosis123,124.”
From Treatment strategies for cryptococcal infection: challenges, advances and future outlook (2021) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660
Self-citationPark, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N. P., Pappas, P. G., & Chiller, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e328322ffac · Cited by 2,062
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 466
Self-citationJarvis, J. N., Lawn, S. D., Vogt, M., Bangani, N., Wood, R., & Harrison, T. S. (2009) · Clinical Infectious Diseases · doi:10.1086/597262 · Cited by 315
Self-citationKambugu, A., Meya, D. B., Rhein, J., O’Brien, M. P., Janoff, E. N., Ronald, A., Kamya, M. R., Mayanja‐Kizza, H., Sande, M. A., Bohjanen, P. R., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587667 · Cited by 299
Jarvis, J. N., Percival, A. L., Bauman, S. K., Pelfrey, J. M., Meintjes, G., Williams, G. N., Longley, N., Harrison, T. S., & Kozel, T. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir613 · Cited by 295
Self-citationMeya, D. B., Manabe, Y. C., Castelnuovo, B., Cook, B. A., Elbireer, A., Kambugu, A. D., Kamya, M. R., Bohjanen, P. R., & Boulware, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/655143 · Cited by 294
Jarvis, J. N., Meintjes, G., Rebe, K., Williams, G. N., Bicanic, T., Williams, A., Schutz, C., Bekker, L.-G., Wood, R., & Harrison, T. S. (2012) · AIDS · doi:10.1097/qad.0b013e3283536a93 · Cited by 290
Self-citationCorticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough, M., Gordon, S. B., Whitty, C. W. M., French, N., Njalale, Y., Chitani, A., Peto, T., Lalloo, D. G., & Zijlstra, E. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065711 · Cited by 278
Bicanic, T. A., Meintjes, G., Wood, R., Hayes, M., Rebe, K. B., Bekker, L., & Harrison, T. S. (2007) · Clinical Infectious Diseases · doi:10.1086/518607 · Cited by 271
Self-citation
Cited by
Sorted by citations
Items 201–300 of 367
Functionalised Dendrimers: Potential Tool for Antiretroviral Therapy
Kharwade, R., More, S., Mahajan, N. M., & Agrawal, P. S. (2020) · Current Nanoscience · doi:10.2174/1573413716666200213114836 · Cited by 10
A Highly Active Triterpene Derivative Capable of Biofilm Damage to Control Cryptococcus spp.
Krummenauer, M. E., Lopes, W., Garcia, A. W. A., Schrank, A., Gnoatto, S. C. B., Kawano, D. F., & Vainstein, M. H. (2019) · Biomolecules · doi:10.3390/biom9120831 · Cited by 11
Challenges in the Development of Novel Anticryptococcal Agents
Krysan, D. J. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0123 · Cited by 10
Gakuru, J., Kagimu, E., Dai, B., Okurut, S., Nsangi, L., Bahr, N. C., Okirwoth, M., Namuju, O. C., Jarvis, J. N., Lawrence, D. S., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae413 · Cited by 9
Self-citationHan, X., Liu, H., Wang, Y., Wang, P., Wang, X., Yi, Y., & Li, X. (2022) · AIDS Research and Therapy · doi:10.1186/s12981-022-00444-5 · Cited by 9
Stott, K. E., Moyo, M., Ahmadu, A., Kajanga, C., Gondwe, E., Chimang’anga, W., Chasweka, M., Leeme, T. B., Molefi, M., Chofle, A. A., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac389 · Cited by 9
Self-citationNeuromeningeal Cryptococcosis and Tuberculosis Coinfection in Bamako: A One-Year Case Series
Ouedraogo, D., Cissoko, Y., Soumaré, M., Akakpo, A. E. A., Loua, O.-O., Konaté, I., Doumbo, S., & Dao, S. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad438 · Cited by 9
Liu, J., Lu, Y., Liu, J., Liang, J., Zhang, Q., Li, H., Zhong, X., Bu, H., Wang, Z., Fan, L., et al. (2023) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-023-04653-2 · Cited by 9
Liang, H., Ye, H., Qu, J., Liu, Y., Zhong, C., Tang, G., Liu, Y., Huang, Y., & Lv, X. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1063-0 · Cited by 9
Sojane, K., Kangethe, R. T., Chang, C. C., Moosa, M. S., Lewin, S. R., French, M. A., & Ndung’u, T. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0209 · Cited by 9
Understanding Causal Pathways in Cryptococcal Meningitis Immune Reconstitution Inflammatory Syndrome
Jarvis, J. N., & Harrison, T. S. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy448 · Cited by 9
Self-citationBoulware, D. R., & Jarvis, J. N. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad123 · Cited by 9
Self-citationGrant, P., Komarow, L., Sanchez, A., Sattler, F. R., Asmuth, D. M., Pollard, R. B., & Zolopa, A. R. (2014) · HIV Clinical Trials · doi:10.1310/hct1504-133 · Cited by 9
Ogbuagu, O. E., & Villanueva, M. S. (2014) · Infectious Disease Reports · doi:10.4081/idr.2014.5576 · Cited by 9
Ming, D. K. Y., & Harrison, T. S. (2017) · British Journal of Hospital Medicine · doi:10.12968/hmed.2017.78.8.c125 · Cited by 9
Self-citationSamuels, T. H. A., Molloy, S. F., Lawrence, D. S., Loyse, A., Kanyama, C., Heyderman, R. S., Lai, W. S., Mfinanga, S., Kivuyo, S. L., Chanda, D. M., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00010-5 · Cited by 8
Self-citationWen, S., Liu, M., Pan, C., Zhang, L., Yan, R., & Xu, Z. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1622349 · Cited by 8
Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
Hurt, W. J., Harrison, T. S., Molloy, S. F., & Bicanic, T. A. (2021) · Journal of Fungi · doi:10.3390/jof7121098 · Cited by 8
Self-citationSong, W., Shen, Y., Wang, Z., Qi, T., Liu, L., Zhang, R.-F., Wang, J., Tang, Y., Chen, J., Sun, J., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001191 · Cited by 8
Impact of biological sex on cryptococcal meningitis mortality in Uganda and South Africa
Stadelman, A., Ssebambulidde, K., Tugume, L., Pastick, K. A., Hullsiek, K. H., Lofgren, S. M., Nuwagira, E., Evans, E. E., Williams, D. A., Muzoora, C. K., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa108 · Cited by 8
Self-citationThree-year mortality in cryptococcal meningitis: Hyperglycemia predict unfavorable outcome
Tsai, S.-T., Lin, F., Chen, P., Chiang, H., & Kuo, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251749 · Cited by 8
Xu, L., Xu, Y., Zheng, Y., Peng, X., Yang, Z., Cao, Q., Xiang, D., & Zhao, H. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13644 · Cited by 26
Zhao, T. S., Xu, X.-L., Lu, Y., Liu, M., Yuan, J., Nie, J.-M., Yu, J., Liu, S., Yang, T., Zhou, G.-Q., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.779181 · Cited by 8
Vidal, J. E., Moraes, C. D. A., de Siqueira, R. E. B., Miranda, N. B., Marcusso, R. M. N., Boulware, D. R., & de Oliveira, A. C. P. (2020) · Mycopathologia · doi:10.1007/s11046-020-00512-2 · Cited by 7
Jiang, Y., Wang, R., Zhou, L., Cheng, J.-H., Luo, Y., Zhu, R., Qiu, W., Zhao, H., Wang, X., Harrison, T. S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993495 · Cited by 8
Self-citationLiang, B., Lin, Z., Li, J., Jiang, R., Zhan, W., & Jian, X. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070994 · Cited by 7
Calcium: a central player in Cryptococcus biology
Squizani, E. D., Reuwsaat, J. C. V., Motta, H., Tavanti, A. G., & Kmetzsch, L. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.03.004 · Cited by 11
McHale, T. C., Akampurira, A., Gerlach, E. S., Atukunda, M., Nicol, M. R., Williams, D. A., Nielsen, K., Bicanic, T. A., Fieberg, A. M., Dai, B., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad596 · Cited by 7
Self-citationWright, E. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000109 · Cited by 7
RNA Interference Screening Reveals Host CaMK4 as a Regulator of Cryptococcal Uptake and Pathogenesis
Srikanta, D., Hole, C. R., Williams, M., Khader, S. A., & Doering, T. L. (2017) · Infection and Immunity · doi:10.1128/iai.00195-17 · Cited by 7
Xu, L., Hu, C., Hu, H., Dai, X., Gao, H., Guo, Y., Huang, Y., Yang, Z., Tao, R., Zhu, B., et al. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1523553 · Cited by 7
Gu, L., Lin, J., Li, A., Yue, J., Wen, W., Liu, W., Lin, Q., Chen, X., Chen, X. H., Wu, J., et al. (2026) · Infectious Diseases of Poverty · doi:10.1186/s40249-025-01408-3 · Cited by 6
Ellis, J. P., Bangdiwala, A. S., Skipper, C. P., Tugume, L., Nsangi, L., Matovu, J., Pastick, K. A., Ssebambulidde, K., Morawski, B. M., Musubire, A. K., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad449 · Cited by 6
Self-citationTeixeira, J. C., de Oliveira, V. F., Gomes, H. R., Ribeiro, S. M., de Araújo, E. D. M. P. A., da Cruz, I. C. L. V., Taborda, M., Magri, A. S. G. K., Vidal, J. E., Nastri, A. C. D. S. S., et al. (2024) · Mycoses · doi:10.1111/myc.13767 · Cited by 6
Chaturvedi, M., Epling, B. P., Pei, L., Sullivan, B., Kuehn, H. S., Hammoud, D. A., Rosenzweig, S. D., Pai, S., Sereti, I., Freeman, A. F., et al. (2025) · Transplant Infectious Disease · doi:10.1111/tid.70000 · Cited by 6
Navabi, N., Montebatsi, M., Scott, M., Gluckman, S. J., & Reid, M. J. A. (2014) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957414555233 · Cited by 6
Paccoud, O., Shuping, L., Mashau, R. C., Greene, G., Quan, V., Meiring, S. T., Govender, N. P., Abrahams, S., Ahmed, K., Avenant, T., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.04.016 · Cited by 6
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
Giamberardino, C. D., Tenor, J. L., Toffaletti, D. L., Palmucci, J. R., Schell, W. A., Boua, J.-V. K., Marius, C., Stott, K. E., Steele, S. L., Hope, W. W., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00818-23 · Cited by 6
Fletcher, A. M., & Bhattacharyya, S. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001393 · Cited by 7
Mkoko, P., Preez, J. D., & Naidoo, S. (2020) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v21i1.1171 · Cited by 5
Stott, K. E., Mohabir, J. T., Bowers, K., Tenor, J. L., Toffaletti, D. L., Unsworth, J., Jimenez‐Valverde, A., Ahmadu, A., Moyo, M., Gondwe, E., et al. (2024) · mBio · doi:10.1128/mbio.01592-24 · Cited by 5
Self-citationTian, Y., Wang, J., Shen, Y., Zhao, J., Hu, J., Zhu, X., Zhu, M., & Guan, M. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.01.015 · Cited by 5
Kessel, J. M., Rossaert, A.-C., Lingscheid, T., Grothe, J. H., Harrer, T., Wyen, C., Tominski, D., Bollinger, T., Kehr, A. K., Kalbitz, S., et al. (2024) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2024.151614 · Cited by 5
Okurut, S., Boulware, D. R., Manabe, Y. C., Tugume, L., Skipper, C. P., Ssebambulidde, K., Rhein, J., Musubire, A. K., Akampurira, A., Okafor, E. C., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012873 · Cited by 6
Zebrafish Larvae as an Experimental Model of Cryptococcal Meningitis
Chalakova, Z., & Johnston, S. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3199-7_4 · Cited by 5
Fungal Infections of the Central Nervous System
Carod-Artal, F. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-70296-4_7 · Cited by 5
Park, Y., Jarvis, J. N., Hu, G., Davis, S. E., Qiu, J. F., Zhang, N., Hollingsworth, C., Loyse, A., Gardina, P. J., Vályi-Nagy, T., et al. (2018) · mBio · doi:10.1128/mbio.02353-18 · Cited by 5
Self-citationBayiyana, A., Okurut, S., Nabatanzi, R., Zziwa, G., Boulware, D. R., Lutwama, F., & Meya, D. (2019) · Journal of Fungi · doi:10.3390/jof5030063 · Cited by 5
Chagas, O. J., Buccheri, R., Melhem, M. D. S. C., Szeszs, W., Martins, M. D. A., de Oliveira, L., Marcusso, R. M. N., & Santos, D. W. D. C. L. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00368-5 · Cited by 5
Pappas, P. G. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu600 · Cited by 5
Giacomelli, A., & Antinori, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00125-7 · Cited by 5
Wang, S., Chen, X., Shi, J., Dai, K., Pan, Q., Liu, J., Xu, X., Peng, F., & Jiang, Y. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.06.021 · Cited by 4
Cryptococcosis: update on therapeutics and new targets
Casadevall, A., & Shoham, S. (2025) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000001138 · Cited by 4
Drug Resistance in Cryptococcosis
Hanson, K. E., Catania, J., Alexander, B. D., & Perfect, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_20 · Cited by 4
Acute kidney injury and other factors associated with mortality in hiv-infected patients
da Silva, G. B., Filho, S. L. A. P., Soares, D. D. S., de Alencar, R. D. N., Peixoto, T. T. T., Nogueira, I. S., Filho, A. M. P. D. O., Menezes, F. H., Cavalcante, M. G., Neto, R. D. J. P., et al. (2018) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.64.06.509 · Cited by 4
Wu, X., & Shen, Y. (2019) · Mycoses · doi:10.1111/myc.12977 · Cited by 4
Immune Reconstitution Inflammatory Syndrome and Paradoxical Reaction
Fong, I. W. (2020) · Springer eBooks · doi:10.1007/978-3-030-36966-8_2 · Cited by 4
Elicer, I., Eugenin, L., Acuña, M. P., Uslar, W., Fernández, A., & Lasso, M. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108423 · Cited by 4
Okafor, E. C., Mukaremera, L., Hullsiek, K. H., Engen, N. W., Tugume, L., Ssebambulidde, K., Musubire, A. K., Nuwagira, E., Mpoza, E., Williams, D. A., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae421 · Cited by 4
Self-citationKasibante, J., Irfanullah, E., Wele, A., Okafor, E. C., Ssebambulidde, K., Okurut, S., Kagimu, E., Gakuru, J., Rutakingirwa, M. K., Mugabi, T., et al. (2024) · Medical Mycology · doi:10.1093/mmy/myae101 · Cited by 5
Self-citationOrsini, J., Blaak, C., Mahmoud, D., & Jeong, Y.-G. (2015) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v5.26098 · Cited by 4
Kiggundu, R., Morawski, B. M., Bahr, N. C., Rhein, J., Musubire, A. K., Williams, D. A., Abassi, M., Nabeta, H. W., Hullsiek, K. H., Meya, D. B., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000812 · Cited by 4
El-Wahab, E. W. A., Farrag, T., & Metwally, M. (2019) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trz107 · Cited by 4
Xu, X.-L., Zhao, T., Huang, Y., Lu, Y., He, X.-J., Wu, Y., Zhang, W., Yu, J., Yang, T., Xu, L., et al. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2047539 · Cited by 4
Okurut, S., Boulware, D. R., Okafor, E. C., Rhein, J., Kajumbula, H., Bagaya, B. S., Bwanga, F., Olobo, J. O., Manabe, Y. C., Meya, D. B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1275443 · Cited by 4
Mejía-Chew, C., Sung, A., Larson, L., Powderly, W. G., & Spec, A. (2020) · Mycoses · doi:10.1111/myc.13199 · Cited by 4
Mahadevan, A., & Krishna, S. S. (2019) · Springer eBooks · doi:10.1007/978-3-030-06088-6_12 · Cited by 4
Ellis, J. P., Groppelli, E., Doyle, R., Lawrence, D. S., Meya, D. B., Boulware, D. R., Mwandumba, H. C., Kanyama, C., Hosseinipour, M. C., Meintjes, G., et al. (2025) · The Lancet HIV · doi:10.1016/s2352-3018(25)00163-8 · Cited by 3
Self-citationKitonsa, J., Kiwanuka, J. P., Anywaine, Z., Kansiime, S., Katumba, K. R., Aeron, N., Beardsley, J., Kibengo, F., Gray, A. M., Kaleebu, P., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008983 · Cited by 3
Evaluation the efficacy of some culture media in melanin production by Cryptococcus neoformans
AL-Zubaidy, I. M. K., & Shabaa, R. A. H. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.07.184 · Cited by 4
Kalata, N. L., Ellis, J. P., Benjamin, L. A., Kampondeni, S. D., Chiodini, P. L., Harrison, T. S., Lalloo, D. G., & Heyderman, R. S. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06425-9 · Cited by 3
Self-citationMadu, U. L., Ogundeji, A. O., Folorunso, O. S., Albertyn, J., Pohl, C. H., & Sebolai, O. M. (2021) · Photochem · doi:10.3390/photochem1020017 · Cited by 3
Rajasingham, R., Nalintya, E., Israelski, D. M., Meya, D. B., Larson, B. A., & Boulware, D. R. (2022) · Medical Mycology · doi:10.1093/mmy/myab078 · Cited by 3
Immunological Analysis of Cryptococcal Meningoencephalitis in a Murine Model
Xu, J., Goughenour, K. D., Underwood, W. R., & Olszewski, M. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3199-7_5 · Cited by 3
Chastain, D. B., Zhang, Q., Chen, X., Young, H. N., Franco‐Paredes, C., Tuells, J., Thompson, G. R., & Henao‐Martínez, A. F. (2024) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361241244967 · Cited by 3
Doan, T. T., Ta, N. T. D., Bui, H. N., Do, T. V., Nong, V. M., Pham, T. N., Duy, C., Co, D. X., & Vu, G. V. (2025) · Clinical Infection in Practice · doi:10.1016/j.clinpr.2025.100497 · Cited by 3
Harrington, B. J., Vorkas, C. K., Kanyama, C., Ngoma, J., Hoffman, I., & Hosseinipour, M. C. (2015) · Tropical Doctor · doi:10.1177/0049475515577024 · Cited by 3
Self-citationBoulware, D. R., & Makadzange, T. (2017) · New England Journal of Medicine · doi:10.1056/nejmcpc1516450 · Cited by 3
Preemptive Therapy for Cryptococcal Meningitis: A Valid Strategy for Latin America?
Vidal, J. E. (2016) · Journal of Fungi · doi:10.3390/jof2020014 · Cited by 3
Dong, S., Dai, X., Pang, L., & Huang, Y. (2025) · Therapeutic Advances in Pulmonary and Critical Care Medicine · doi:10.1177/29768675251363301 · Cited by 2
Pathophysiology of intracranial hypertension in cryptococcal meningoencephalitis
Wieren, A. V., & Casadevall, A. (2026) · mBio · doi:10.1128/mbio.00312-26 · Cited by 2
Dai, K., Jian, X., Luo, C., Wang, S., Pan, Q., Xu, X., Liu, J., Peng, F., Chen, Y., & Jiang, Y. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag410 · Cited by 2
Warrell, C. E., Macrae, C., McLean, A. R. D., Wilkins, E., Ashley, E. A., Smithuis, F. M., & Tun, N. N. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06049-z · Cited by 2
Damasceno, L. S., Cézar, R. C., Canuto, M. C. D. S., Neto, J. D. P. B., & Leitão, T. D. M. J. S. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101407 · Cited by 2
Cao, C., Luo, L., Hu, Y., Huang, T., Gao, S., Ling, C., He, H., & Guo, Y. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.03.127 · Cited by 2
Hale, G., Adžemović, T., Hullsiek, K. H., Mulwana, S., Ndyetukira, J. F., Sadiq, A., Kabahubya, M., Ayebare, P., Nankungu, L., Namudde, A., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae354 · Cited by 3
Self-citationNsangi, L., Hullsiek, K. H., Dai, B., Namudde, A., Menya, G., Ssebambulidde, K., Tugume, L., Nuwagira, E., Rhein, J., Williams, D. A., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf054 · Cited by 2
HIV-associated Cryptococcal Meningitis: a Review of Novel Short-Course and Oral Therapies
Moeng, L. R., Milburn, J. A., Jarvis, J. N., & Lawrence, D. S. (2020) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-020-00239-0 · Cited by 2
Self-citationTherapy of AIDS-Related Cryptococcal Meningitis
Stone, N. R. H., & Bicanic, T. A. (2014) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-014-0018-0 · Cited by 2
Self-citationGreene, G., Vallabhaneni, S., Chung, J. H., & Chiller, T. M. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-015-0246-x · Cited by 2
Infections in HIV-Infected Patients
Ogbuagu, O. E., & Bruce, R. D. (2018) · Springer eBooks · doi:10.1007/978-3-319-77674-3_13 · Cited by 2
Ross, A. J., & Ndayishimiye, E. (2019) · South African Family Practice · doi:10.1080/20786190.2019.1607480 · Cited by 2
Stone, N. R. H., & Schwartz, I. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1756 · Cited by 2
Low-cerebrospinal fluid white cell counts and mortality in HIV-associated pneumococcal meningitis
Tenforde, M. W., Meintjes, G., Mokomane, M., Harrison, T. S., Mine, M., & Jarvis, J. N. (2019) · AIDS · doi:10.1097/qad.0000000000002241 · Cited by 2
Self-citationDiagnostic and mortality outcomes in a cohort of adult meningitis suspects in KwaZulu-Natal
Nonkala, O., Aldous, C. M., & Wilson, D. (2017) · Southern African Journal of Infectious Diseases · doi:10.1080/23120053.2017.1371986 · Cited by 1
Self-citationMeningoencephalitis and optical neuritis caused by CRYPTOCOCCUS GATTII in an immunocompetent patient
de Souza, B. A., Souza, L. C. S., Guilarde, A. O., Barbosa, A. A. C., Filho, L. A. F., & de Souza, M. A. (2020) · Revista de Patologia Tropical / Journal of Tropical Pathology · doi:10.5216/rpt.v49i4.67163 · Cited by 1
Ellis, J. P., Kalata, N. L., Dziwani, E., Matope, A., Wang, D., Molloy, S. F., Harrison, T. S., Lalloo, D. G., Sloan, D. J., & Heyderman, R. S. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16426.1 · Cited by 1
Self-citationExploring immunotherapy to control human infectious diseases
Rai, P., Mehrotra, S., & Prajapati, V. K. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.10.010 · Cited by 1
Bennett, J. E., Anjum, S. H., & Williamson, P. R. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf490 · Cited by 1
Liang, Y., Dong, X., Deng, Y., Lin, Z., Zheng, C., Li, J., Lin, Y., Zhang, H., Wang, X., Lin, W., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05321-3 · Cited by 1
Metadata
- Authors
- Jarvis, J. N., Bicanic, T., Loyse, A., Namarika, D., Jackson, A., Nussbaum, J. C., Longley, N., Muzoora, C., Phulusa, J., Taseera, K., Kanyembe, C., Wilson, D., Hosseinipour, M. C., Brouwer, A. E., Limmathurotsakul, D., White, N., van der Horst, C., Wood, R., Meintjes, G., Bradley, J., Jaffar, S., & Harrison, T.
- Affiliations
- University of Cape Town (ZA)
- St George's, University of London (GB)
- University of California, San Francisco (US)
- Mbarara University of Science and Technology (UG)
- Edendale Hospital (ZA)
- Radboud University Medical Center (NL)
- Mahidol University (TH)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Jarvis, Joseph N.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-06
- Volume
- 58
- Issue
- 5
- Pages
- 736-745
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3922213
- OpenAlex
- W2101195119
- Cited by
- 367
- References
- 30
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 30 · 2023: 22 · 2022: 24 · 2021: 28 · 2020: 31 · 2019: 39 · 2018: 39 · 2017: 37 · 2016: 28 · 2015: 29 · 2014: 19
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Greater South Information System
- Funders
- Wellcome Trust (84323)
- National Institute for Health and Care Research (CL-2012-20-001)
- Medical Research Council (MR/K012126/1)
- National Institute of Allergy and Infectious Diseases (P30AI045008, P30AI050410)
- Fogarty International Center (D43TW001039)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- cryptococcal meningitis, HIV, mortality determinants, altered mental status, immune reconstitution inflammatory syndrome, amphotericin B, fluconazole, antiretroviral therapy, anemia, CSF opening pressure, age, white blood cell count
- MeSH terms
- Adult, Africa, Mental Disorders, Cerebrospinal Fluid, Female, Humans, Longitudinal Studies, Male, Prospective Studies, Risk Factors, Thailand, Colony Count, Microbial, Cohort Studies, HIV Infections, Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review